- Quantum Numbers (QNC) has appointed Francis Bellido to its board of directors
- Bellido has spent his career overseeing and leading the development of several organizations in the healthcare industry
- Notably, Bellido managed a C$300 million life science investment fund
- Following Bellido’s appointment, the company also granted him incentive stock options to purchase 750,000 common shares
- Quantum Numbers closed at C$0.08 per share
Quantum Numbers (QNC) has appointed Francis Bellido to its board of directors.
Bellido has spent his career overseeing and leading the development of several organizations in the healthcare industry.
The company says he brings strong financial management expertise, deep operating and leadership experience and a global business perspective acquired over 30 years.
Notably, Bellido managed a C$300 million life science investment fund (SGF-Santé) that produced several important and key players in the medical device industry.
He holds a PhD in medical microbiology from the University of Geneva and an MBA with a concentration in finance from the University of Quebec at Montreal.
Quantum Numbers Chairman Pierre Paul Samson said Bellido’s experience is relevant to the company’s future plans.
“His established network in healthcare will help us position our product offering with the right industry targets. There’s unanimity with our current board members, this latest appointment will help QNC move to the next level.”
Following Bellido’s appointment to Quantum’s board, the company also granted him incentive stock options to purchase 750,000 common shares. The exercise price of the options is 6.5 cents per share.
Quantum Numbers is based in Montreal and is a developer of cryptographic solutions.
Quantum Numbers closed at C$0.08 per share.
